This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Porcu, P. Articles by Madeddu, P. Search for Related Content PubMed PubMed Citation Articles by Porcu, P. Articles by Madeddu, P. Pubmed/NCBI databases Substance via MeSH Related Collections Angiogenesis Gene expression Gene regulation Peripheral vascular disease

(Circulation. 2002;105:67.)
© 2002 American Heart Association, Inc.

Clinical Investigation and Reports

Reversal of Angiogenic Growth Factor Upregulation by Revascularization of Lower Limb Ischemia

Paolo Porcu, MD; Costanza Emanueli, PhD; Maria Kapatsoris, MD; Julie Chao, PhD; Lee Chao, PhD; Paolo Madeddu, MD, FAHA

From the Institute of Internal Medicine (M.K., P.M.) and Vascular Surgery (P.P.), Medical University of Sassari, Sassari, Italy; the Cardiovascular Medicine and Gene Therapy Section of the National Laboratory of the National Institute of Biostructures and Biosystems (C.E., P.M.), Osilo, Italy; and the Department of Biochemistry and Molecular Biology, Medical University of South Carolina (J.C., L.C.), Charleston.

Correspondence to Paolo Madeddu, MD, FAHA, Institute of Internal Medicine, Viale S. Pietro 8, 07100 Sassari, Italy. E-mail madeddu{at}yahoo.com

Background— Tissue kallikrein (tK) and vascular endothelial growth factor (VEGF) are potent angiogenic agents. Upregulation of tK or VEGF was documented in animal models of acute ischemia, yet it remains unknown whether these endothelial cell mitogens are overexpressed in chronic peripheral vascular insufficiency.

Methods and Results— Circulating tK and VEGF were measured in 36 patients with symptomatic peripheral vascular disease before and after surgical revascularization. In 6 patients without symptoms at rest, tK was assayed after exercise stress test. VEGF levels fell within the normal range in all patients (96±11 versus 109±13 pg/mL in healthy control subjects, P=NS) and remained unchanged after revascularization. In contrast, tK expression was upregulated in 34 of 36 patients (1107±203 versus 85±10 pg/mL in control subjects, P<0.05), with no further increase after exercise. Tissue kallikrein levels in the venous effluent of ischemic limbs were found to be positively correlated with the number of angiographically recognizable collateral vessels (P<0.001). Follow-up studies documented reversal of tK upregulation after revascularization (P<0.01), whereas no change was observed in venous samples from untouched legs.

Conclusions— Induction of tK could represent a compensatory response to chronic arterial insufficiency, attempting to maintain an adequate tissue perfusion. Heterogeneous statement of growth factors may have important implications in reparative and therapeutic angiogenesis.

Key Words: angiogenesis • atherosclerosis • bradykinin • revascularization

This article has been cited by other articles:

				H. Leong-Poi, M. A. Kuliszewski, M. Lekas, M. Sibbald, K. Teichert-Kuliszewska, A. L. Klibanov, D. J. Stewart, and J. R. Lindner Therapeutic Arteriogenesis by Ultrasound-Mediated VEGF165 Plasmid Gene Delivery to Chronically Ischemic Skeletal Muscle Circ. Res., August 3, 2007; 101(3): 295 - 303. [Abstract] [Full Text] [PDF]

				P. Coats and R. Wadsworth Marriage of resistance and conduit arteries breeds critical limb ischemia Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1044 - H1050. [Abstract] [Full Text] [PDF]

				A Del Rosso, O Distler, A F Milia, C Emanueli, L Ibba-Manneschi, S Guiducci, M L Conforti, S Generini, A Pignone, S Gay, et al. Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement Ann Rheum Dis, March 1, 2005; 64(3): 382 - 387. [Abstract] [Full Text] [PDF]

				T. G. Ebrahimian, R. Tamarat, M. Clergue, M. Duriez, B. I. Levy, and J.-S. Silvestre Dual Effect of Angiotensin-Converting Enzyme Inhibition on Angiogenesis in Type 1 Diabetic Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 65 - 70. [Abstract] [Full Text] [PDF]

				C. Emanueli, M. B. Salis, S. Van Linthout, M. Meloni, E. Desortes, J.-S. Silvestre, M. Clergue, C. D. Figueroa, S. Gadau, G. Condorelli, et al. Akt/Protein Kinase B and Endothelial Nitric Oxide Synthase Mediate Muscular Neovascularization Induced by Tissue Kallikrein Gene Transfer Circulation, September 21, 2004; 110(12): 1638 - 1644. [Abstract] [Full Text] [PDF]

				R. E. Waters, R. L. Terjung, K. G. Peters, and B. H. Annex Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents J Appl Physiol, August 1, 2004; 97(2): 773 - 780. [Abstract] [Full Text] [PDF]

				P. Porcu, C. Emanueli, E. Desortes, G. M. Marongiu, F. Piredda, L. Chao, J. Chao, and P. Madeddu Circulating Tissue Kallikrein Levels Correlate With Severity of Carotid Atherosclerosis Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1104 - 1110. [Abstract] [Full Text] [PDF]

				C. Emanueli, M. B. Salis, A. Pinna, T. Stacca, A. F. Milia, A. Spano, J. Chao, L. Chao, L. Sciola, and P. Madeddu Prevention of Diabetes-Induced Microangiopathy by Human Tissue Kallikrein Gene Transfer Circulation, August 20, 2002; 106(8): 993 - 999. [Abstract] [Full Text] [PDF]